Rosen Law Firm is investigating potential securities claims on behalf of shareholders of The Ensign Group, Inc. following allegations that the company may have issued materially misleading business information. The investigation stems from a June 8, 2026 short seller report by Hunterbrook alleging that Ensign's business model relies on inadequate patient care and gaming quality metrics, with claims that patients have suffered and died as a result. On that news, Ensign Group shares fell 8.15%. The law firm is preparing a class action to recover investor losses and encourages affected shareholders to contact them.
The Ensign Group IncInvestigation and potential class action over alleged misleading business information following short seller report.
